Slaughter and May is advising Mediclinic in connection with the c.£1bn recommended cash offer for Spire Healthcare Group plc

Slaughter and May is advising long standing client Mediclinic in connection with the c.£1bn recommended cash offer for Spire Healthcare Group plc by Tulip UK Bidco Limited, a newly formed company to be indirectly owned by a consortium of funds managed or advised by Toscafund Asset Management LLP, THCP Advisory Limited ("Three Hills") and Ares Management Limited.

Mediclinic is the largest shareholder in Spire, holding approximately 29.8 per cent. of Spire's issued ordinary share capital, and has entered into an irrevocable undertaking to vote in favour of the acquisition.